[Letter to John P. Moore from Rick Loftus]

'I.'KT ) '9? [:FC1, lFP?

F'. 1

FAX
DATE: 10/ /93
TO: John Moore
FROM: Rick Loftus
CC:
RE: gpl60
NO. OF PAGES j
Hi John. Thanks for the note.
According to Derek Hodel of AIDS Action, the Kennedy amendment is
now going to closely resemble the Waxman amendment, to avoid
putting the appropriation back into c0mmittee. If the two versions
of the bill are the same or are close, there is no need to risk a
hostile conference with L.ivinston and other good ol'boys.
We expect, therefore, to have the Kennedy amendment in the next 4
days. A full Congressional vote on the military FY1993
appropriation will happen before October 21 and perhaps as soon as
the 15th_ I am optimistic that we will get the amendment through
the Senate, and that the 3 agencies named will indeed hold up the
single product trial. (Kennedy will add language to the report on
the Senate version of the legislation to press for putting the
funds into basic science.)
On the other side of the scandal: A little birdie just leaked me
some memos from the Jackson foundation regarding everyone's
favorite immunogen. At least one patient in the Phase 2 study had
a precipitous decline in CD4's (83% loss in 14 months). The trial
MD states clearly in her memo to Redfield that she believes the
vaccine is responsible.
There may have been one more person who suffered similar effects,
but the Army changes patient numbers once they exclude someone from
a trial, so identities become muddled. Of course, none of these
patients appeared in the Amsterdam presentation, or in any
presentation or write up.
I know that many reporters have seen this data.- Why aren't they
exposing the potential dangers of this vaccine?
I will be in touch early next week reo long-term survivor study
issue.
11111 55 III 11111 11110446.009 iii 1111 1
5571095.0446.009